185 results
8-K
EX-99.1
ANIK
Anika Therapeutics Inc.
13 Mar 24
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
4:10pm
%, on sustained above-market growth offset by some unfavorable order timing
Joint Preservation and Restoration of $58 to $60.5 million, up 6% to 10%
Non-Orthopedic
8-K
EX-99.1
abhnm
9 May 23
Anika Reports First Quarter 2023 Financial Results
4:11pm
PRER14A
itk3xmu82dvbw ls988
5 Apr 23
Preliminary revised proxy
11:19am
DEFA14A
qecqtyllhyavvei9u5
27 Apr 22
Additional proxy soliciting materials
5:00pm
DEFA14A
tmb37
30 Apr 21
Additional proxy soliciting materials
4:30pm